Protalix BioTherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 1.12 M | $2.10 M | 16.96% | 1.52% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 387,921 | $729,291 | 3.79% | 0.53% |
| GSA CAPITAL PARTNERS LLP | 02/07/2025 | 305,749 | $575,000 | -29.75% | 0.42% |
| STRATOS WEALTH PARTNERS, LTD. | 01/27/2025 | 270,000 | $507,600 | 0.00% | 0.37% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 224,657 | $422,354 | 25.66% | 0.31% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 181,400 | $341,032 | -1.30% | 0.25% |
| JANE STREET GROUP, LLC | 02/14/2025 | 113,616 | $213,598 | 147.25% | 0.15% |
| MARSHALL WACE, LLP | 02/13/2025 | 101,899 | $191,570 | 100.00% | 0.14% |
| SQUAREPOINT OPS LLC | 02/14/2025 | 73,940 | $139,007 | 33.42% | 0.10% |
| ORIN GREEN FINANCIAL, LLC | 02/19/2025 | 72,000 | $135,360 | 0.00% | 0.10% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 02/14/2025 | 53,507 | $100,593 | 13.67% | 0.07% |
| COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 50,000 | $94,000 | 0.00% | 0.07% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 49,710 | $93,455 | -1.06% | 0.07% |
| HSBC HOLDINGS PLC | 02/14/2025 | 40,023 | $75,643 | 0.00% | 0.05% |
| PRUDENTIAL FINANCIAL INC | 02/11/2025 | 36,400 | $68,432 | 100.00% | 0.05% |
| BARCLAYS PLC | 02/13/2025 | 34,323 | $65,000 | 0.00% | 0.05% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 34,276 | $64,000 | -21.00% | 0.05% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 29,307 | $55,097 | 24.07% | 0.04% |
| CAPITAL PERFORMANCE ADVISORS LLP | 01/31/2025 | 25,976 | $48,835 | 0.00% | 0.04% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 24,867 | $46,750 | -31.76% | 0.03% |
| APTUS CAPITAL ADVISORS, LLC | 02/14/2025 | 23,363 | $43,922 | 4.59% | 0.03% |
| PFG INVESTMENTS, LLC | 01/22/2025 | 20,730 | $38,972 | 100.00% | 0.03% |
| Y-INTERCEPT (HONG KONG) LTD | 02/04/2025 | 18,818 | $35,378 | 100.00% | 0.03% |
| UBS GROUP AG | 02/14/2025 | 18,178 | $34,175 | 6,125.34% | 0.02% |
| LIDO ADVISORS, LLC | 02/14/2025 | 15,554 | $29,242 | 0.00% | 0.02% |
| KESTRA ADVISORY SERVICES, LLC | 02/10/2025 | 14,000 | $26,320 | -12.50% | 0.02% |
| ALTSHULER SHAHAM LTD | 02/13/2025 | 12,142 | $22,827 | 0.00% | 0.02% |
| 02/10/2025 | 10,200 | $19,176 | 0.00% | 0.01% | |
| HARBOUR INVESTMENT MANAGEMENT LLC | 02/10/2025 | 10,100 | $18,988 | 0.00% | 0.01% |
| TD WATERHOUSE CANADA INC. | 02/13/2025 | 6,000 | $11,100 | 0.00% | 0.01% |
| TRUVESTMENTS CAPITAL LLC | 02/10/2025 | 2,458 | $4,621 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/12/2025 | 1,595 | $2,999 | 0.00% | 0.00% |
| LAZARD ASSET MANAGEMENT LLC | 02/14/2025 | 1,255 | $2,000 | 100.00% | 0.00% |
| POINT72 (DIFC) LTD | 02/14/2025 | 901 | $1,694 | -92.23% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 716 | $1,346 | 100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 02/14/2025 | 656 | $1,233 | 100.00% | 0.00% |
| CITIGROUP INC | 02/12/2025 | 632 | $1,188 | 100.00% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 01/28/2025 | 300 | $564 | 0.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 02/14/2025 | 250 | $470 | 0.00% | 0.00% |
| Y.D. MORE INVESTMENTS LTD | 01/27/2025 | 220 | $414 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 200 | $204 | 0.00% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 02/05/2025 | 39 | $74 | 0.00% | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| 01/31/2025 | 0 | $0 | -100.00% | 0.00% | |
| XTX TOPCO LTD | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Protalix BioTherapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 55 institutional investors and hedge funds held shares of Protalix BioTherapeutics, Inc.. The most heavily invested institutionals were:
RENAISSANCE TECHNOLOGIES LLC: 1.12 M
MILLENNIUM MANAGEMENT LLC: 387,921
GSA CAPITAL PARTNERS LLP: 305,749
Stratos Wealth Partners, LTD.: 270,000
BlackRock Funding, Inc. /DE: 224,657
BRIDGEWAY CAPITAL MANAGEMENT, LLC: 181,400
6.07% of Protalix BioTherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.95 M shares in the last 24 months. This purchase volume represents approximately $8.80 M in transactions.